AstraZeneca Says It's Likely to Run Fresh Global Vaccine Trial
Bloomberg, 27 Nov 2020
Nov.26 -- AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to Pascal Soriot, the company's ...